These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 35386312)
1. Brain-targeting, acid-responsive antioxidant nanoparticles for stroke treatment and drug delivery. Zhang S; Peng B; Chen Z; Yu J; Deng G; Bao Y; Ma C; Du F; Sheu WC; Kimberly WT; Simard JM; Coman D; Chen Q; Hyder F; Zhou J; Sheth KN Bioact Mater; 2022 Oct; 16():57-65. PubMed ID: 35386312 [TBL] [Abstract][Full Text] [Related]
2. Intracisternal administration of tanshinone IIA-loaded nanoparticles leads to reduced tissue injury and functional deficits in a porcine model of ischemic stroke. Waters ES; Kaiser EE; Yang X; Fagan MM; Scheulin KM; Jeon JH; Shin SK; Kinder HA; Kumar A; Platt SR; Duberstein KJ; Park HJ; Xie J; West FD IBRO Neurosci Rep; 2021 Jun; 10():18-30. PubMed ID: 33842909 [TBL] [Abstract][Full Text] [Related]
3. Anti-edema and antioxidant combination therapy for ischemic stroke via glyburide-loaded betulinic acid nanoparticles. Deng G; Ma C; Zhao H; Zhang S; Liu J; Liu F; Chen Z; Chen AT; Yang X; Avery J; Zou P; Du F; Lim KP; Holden D; Li S; Carson RE; Huang Y; Chen Q; Kimberly WT; Simard JM; Sheth KN; Zhou J Theranostics; 2019; 9(23):6991-7002. PubMed ID: 31660082 [TBL] [Abstract][Full Text] [Related]
4. Brain Targeting, Antioxidant Polymeric Nanoparticles for Stroke Drug Delivery and Therapy. Wu H; Peng B; Mohammed FS; Gao X; Qin Z; Sheth KN; Zhou J; Jiang Z Small; 2022 Jun; 18(22):e2107126. PubMed ID: 35306743 [TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy. Saneja A; Kumar R; Singh A; Dhar Dubey R; Mintoo MJ; Singh G; Mondhe DM; Panda AK; Gupta PN Int J Pharm; 2017 Oct; 531(1):153-166. PubMed ID: 28823888 [TBL] [Abstract][Full Text] [Related]
6. Targeted Treatment of Ischemic Stroke by Bioactive Nanoparticle-Derived Reactive Oxygen Species Responsive and Inflammation-Resolving Nanotherapies. Yuan J; Li L; Yang Q; Ran H; Wang J; Hu K; Pu W; Huang J; Wen L; Zhou L; Jiang Y; Xiong X; Zhang J; Zhou Z ACS Nano; 2021 Oct; 15(10):16076-16094. PubMed ID: 34606239 [TBL] [Abstract][Full Text] [Related]
7. Betulinic acid self-assembled nanoparticles for effective treatment of glioblastoma. Li Y; Wang Y; Gao L; Tan Y; Cai J; Ye Z; Chen AT; Xu Y; Zhao L; Tong S; Sun Q; Liu B; Zhang S; Tian D; Deng G; Zhou J; Chen Q J Nanobiotechnology; 2022 Jan; 20(1):39. PubMed ID: 35062946 [TBL] [Abstract][Full Text] [Related]
8. Self-assembled targeted folate-conjugated eight-arm-polyethylene glycol-betulinic acid nanoparticles for co-delivery of anticancer drugs. Dai L; Cao X; Liu KF; Li CX; Zhang GF; Deng LH; Si CL; He J; Lei JD J Mater Chem B; 2015 May; 3(18):3754-3766. PubMed ID: 32262850 [TBL] [Abstract][Full Text] [Related]
9. Thrombin-Responsive, Brain-Targeting Nanoparticles for Improved Stroke Therapy. Guo X; Deng G; Liu J; Zou P; Du F; Liu F; Chen AT; Hu R; Li M; Zhang S; Tang Z; Han L; Liu J; Sheth KN; Chen Q; Gou X; Zhou J ACS Nano; 2018 Aug; 12(8):8723-8732. PubMed ID: 30107729 [TBL] [Abstract][Full Text] [Related]
10. A multifunctional CeO Chen Z; Xu L; Gao X; Wang C; Li R; Xu J; Zhang M; Panichayupakaranant P; Chen H Food Res Int; 2020 Nov; 137():109674. PubMed ID: 33233251 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic benefits of nanoparticles in stroke. Panagiotou S; Saha S Front Neurosci; 2015; 9():182. PubMed ID: 26041986 [TBL] [Abstract][Full Text] [Related]
12. α-Amylase- and Redox-Responsive Nanoparticles for Tumor-Targeted Drug Delivery. Li Y; Hu H; Zhou Q; Ao Y; Xiao C; Wan J; Wan Y; Xu H; Li Z; Yang X ACS Appl Mater Interfaces; 2017 Jun; 9(22):19215-19230. PubMed ID: 28513132 [TBL] [Abstract][Full Text] [Related]
13. A Carrier-Free Folate Receptor-Targeted Ursolic Acid/Methotrexate Nanodelivery System for Synergetic Anticancer Therapy. Lan JS; Qin YH; Liu L; Zeng RF; Yang Y; Wang K; Ding Y; Zhang T; Ho RJY Int J Nanomedicine; 2021; 16():1775-1787. PubMed ID: 33692622 [TBL] [Abstract][Full Text] [Related]
14. Preparation of Betulinic Acid Galactosylated Chitosan Nanoparticles and Their Effect on Liver Fibrosis. Wu ZC; Liu XY; Liu JY; Piao JS; Piao MG Int J Nanomedicine; 2022; 17():4195-4210. PubMed ID: 36134203 [TBL] [Abstract][Full Text] [Related]
15. Characterization and Cytotoxicity of Polyprenol Lipid and Vitamin E-TPGS Hybrid Nanoparticles for Betulinic Acid and Low-Substituted Hydroxyl Fullerenol in MHCC97H and L02 Cells. Tao R; Wang C; Lu Y; Zhang C; Zhou H; Chen H; Li W Int J Nanomedicine; 2020; 15():2733-2749. PubMed ID: 32368052 [TBL] [Abstract][Full Text] [Related]
16. Amphiphilic block copolymer NPs obtained by coupling ricinoleic acid/sebacic acids and mPEG: Synthesis, characterization, and controlled release of paclitaxel. Zhou S; Sun W; Zhai Y J Biomater Sci Polym Ed; 2018 Dec; 29(18):2201-2217. PubMed ID: 30285542 [TBL] [Abstract][Full Text] [Related]
17. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery. Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577 [TBL] [Abstract][Full Text] [Related]
18. Development of L-carnosine functionalized iron oxide nanoparticles loaded with dexamethasone for simultaneous therapeutic potential of blood brain barrier crossing and ischemic stroke treatment. Lu X; Zhang Y; Wang L; Li G; Gao J; Wang Y Drug Deliv; 2021 Dec; 28(1):380-389. PubMed ID: 33586561 [TBL] [Abstract][Full Text] [Related]
19. Superior antioxidant and anti-ischemic neuroprotective effects of cerebrolysin in heat stroke following intoxication of engineered metal Ag and Cu nanoparticles: A comparative biochemical and physiological study with other stroke therapies. Sharma HS; Muresanu DF; Ozkizilcik A; Sahib S; Tian ZR; Lafuente JV; Castellani RJ; Nozari A; Feng L; Buzoianu AD; Menon PK; Patnaik R; Wiklund L; Sharma A Prog Brain Res; 2021; 266():301-348. PubMed ID: 34689862 [TBL] [Abstract][Full Text] [Related]
20. Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma. Ruan C; Liu L; Lu Y; Zhang Y; He X; Chen X; Zhang Y; Chen Q; Guo Q; Sun T; Jiang C Acta Pharm Sin B; 2018 Jan; 8(1):85-96. PubMed ID: 29872625 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]